China's Hualan Bio gets WHO nod for influenza vaccine

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2015

Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza vaccine and is taken into UN purchase plan. Flu is one of the most s...Read more

Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2016

Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the treatment of breast cancer, non-small cell lung cancer, prostate cancer,...Read more

German firm proceeds on ebola vaccine trial

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2015

Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the clinical trial of its investigational vaccine against Ebola virus diseas...Read more

Merck's Ebola vaccine found promising in clinical trials

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2015

Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "highly effective," in clinical trials. The vaccine was tested on more th...Read more

Teva recalls Adrucil injection for potential foriegn particle presence

Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Jul, 2015

Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential presence of particulate matter identified as aggregate of silicone rubber...Read more

Drug resistance keeps malaria threat alive in India

Vaccines |  Analysis | By Rahul Koul Koul | 0 Comment | 02 Jul, 2012

The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 percent, says a report by ORG IMS in Nov 2011. According to statistics...Read more

New vaccine against Hepatatis B developed by Cuba

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2015

Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNasvac, developed in cooperation French company Abivax, is currently und...Read more

Malaria vaccine, Mosquirix, gets European nod

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2015

Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...Read more

Novavax's Ebola vaccine shows promise in human trial

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2015

Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early stage human clinical trial. The vaccine induced a substantial immune...Read more

No more needles, no more pain!

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2015

Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a new technique that can deliver vaccines without needles. The new met...Read more

Shanghai BravoBio wins BioSpectrum award for role in China vaccine industry

Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign markets remains a challenge. Shanghai BravoBio, which has a strong and ...Read more

WHO and World Food Program join forces to reach zero Ebola cases

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2015

Singapore: WHO and United Nations World Food Program (WFP) have come together to build logistics strength for Ebola-affected countries of Guinea, Liberia and Sierra Leone to help get the cu...Read more

FDA nod for Sanofi quadrivalent flu vaccine

Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain influenza vaccine, Fluzone Quadrivalent, which is the newest addition...Read more

Vaccine for AIDS in ten years: Bill Gates

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2015

Singapore: With no cure or vaccine available for AIDS, that is spreading across the globe like a wide epidemic, billionaire philanthropist Mr Bill Gates, who spends millions of dollars on A...Read more

AIDS 2014: Slash in fund jolts HIV research

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

Singapore: Investment in HIV prevention research has declined posing a challenge to the pipeline of HIV prevention products in various stages of development and implementation of an effecti...Read more

Novartis completes divestiture of influenza vaccines business

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

Singapore: Novartis has announced that it has completed the divestiture of its influenza vaccine unit to CSL Limited. This marks the end of a series of transactions previously announced and...Read more

J&J's HIV vaccine to begin human trials

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2015

Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Johnson has shown promise in early clinical trials. As per reports the ...Read more

Agilent, A*Star, French univ sign biologics MoU

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*...Read more